The company’s success was greater than expected, said Stuart Essig, Integra’s CEO. The company reported a GAAP net income of $16.5 million, an increase from the third quarter of 2009.
Integra’s orthopedic business has earned $72,970 during the third quarter, a 13.8 percent increase over last year. The company’s neurosurgery business also experienced a 3.8 percent increase to $69,816.
Read the release on Integra LifeSciences 3Q FY 2010 financial report.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences Annouces Milestone for Vu a-POD Device
– Integra LifeSciences Contracts With The Broadlane Group
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
